LazyNews
NORMAL
Artificial Intelligence

A tiny GLP-1 implant is the latest bet to help patients maintain their weight loss - CNBC

Vivani Medical is developing an implant of semaglutide, the active ingredient in Novo Nordisk's obesity injection Wegovy and diabetes counterpart Ozempic.

Share:
Losing weight with GLP-1 drugs is only half the battle. Keeping it off long term has proved even harder. Factors such as side effects, high out-of-pocket costs, injection fatigue and stigma around o… [+12838 chars]

Community

Comments

Share your perspective. Thoughtful contributions make LazyNews useful.

0 comments

Log in to join the discussion.

Loading comments…